BioPharmaceutical Business Intelligence

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Novartis
Moodys
Baxter
US Department of Justice
Daiichi Sankyo
Chinese Patent Office
Dow
Federal Trade Commission
McKesson

Generated: January 23, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 084364

« Back to Dashboard

NDA 084364 describes TRIHEXYPHENIDYL HYDROCHLORIDE, which is a drug marketed by Mikart, Pharm Assoc, Pharm Ventures, Hikma Pharms, Natco Pharma Ltd, Nylos, Vangard, Vintage Pharms Llc, and Watson Labs, and is included in thirteen NDAs. It is available from eighteen suppliers. Additional details are available on the TRIHEXYPHENIDYL HYDROCHLORIDE profile page.

The generic ingredient in TRIHEXYPHENIDYL HYDROCHLORIDE is trihexyphenidyl hydrochloride. There are three drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the trihexyphenidyl hydrochloride profile page.
Summary for 084364
Tradename:TRIHEXYPHENIDYL HYDROCHLORIDE
Applicant:Watson Labs
Ingredient:trihexyphenidyl hydrochloride
Patents:0
Therapeutic Class:Antiparkinson Agents
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 084364
Suppliers and Packaging for NDA: 084364
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
TRIHEXYPHENIDYL HYDROCHLORIDE trihexyphenidyl hydrochloride TABLET;ORAL 084364 ANDA Actavis Pharma, Inc. 0591-5337 0591-5337-01 100 TABLET in 1 BOTTLE, PLASTIC (0591-5337-01)
TRIHEXYPHENIDYL HYDROCHLORIDE trihexyphenidyl hydrochloride TABLET;ORAL 084364 ANDA Actavis Pharma, Inc. 0591-5337 0591-5337-10 1000 TABLET in 1 BOTTLE, PLASTIC (0591-5337-10)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength5MG
Approval Date:Approved Prior to Jan 1, 1982TE:AARLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
Baxter
Chinese Patent Office
Colorcon
QuintilesIMS
UBS
Julphar
Boehringer Ingelheim
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot